Hepatitis B virus reactivation in rheumatoid arthritis

doi:10.12998/wjcc.v10.i1.12

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 10, Issue 1

This Article

Academic Content and Language Evaluation of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (5838)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-2) series, Tables (1-2) series.

Item

Count

PDF

363

WORD

179

HTML

3757

Figures (1-2)

256

Tables (1-2)

339

Sum=4894

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

343

Download

601

Sum=944

Jan 7, 2022 (publication date) through Nov 3, 2024

Times Cited of This Article

Times Cited (6)

Journal Information of This Article

Publication Name

World Journal of Clinical Cases

ISSN

2307-8960

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Minireviews

World J Clin Cases. Jan 7, 2022; 10(1): 12-22
Published online Jan 7, 2022. doi: 10.12998/wjcc.v10.i1.12

Full Size Figure Download Figure

Figure 2 Suggested process for screening, monitoring, and prevention of hepatitis B virus reactivation. HBsAg: Hepatitis B surface antigen; anti-HBs: Antibody to hepatitis B surface antibody; anti-HBc: Antibody to hepatitis B core antigen; ISDs: Immunosuppressive drugs; CS: Corticosteroid; HBV: Hepatitis B virus.

Citation: Wu YL, Ke J, Zhang BY, Zhao D. Hepatitis B virus reactivation in rheumatoid arthritis. World J Clin Cases 2022; 10(1): 12-22
URL: https://www.wjgnet.com/2307-8960/full/v10/i1/12.htm
DOI: https://dx.doi.org/10.12998/wjcc.v10.i1.12